Haoxi Health Technology Limited (HAO) Comparison with companies in other sectors?

Haoxi Health Technology Limited has a share price of 19.40M. You can analyze Haoxi Health Technology Limited (HAO) competitors across different market sectors through stock heatmaps.

What are HAO's NET and operating margins?

Haoxi Health Technology Limited (HAO) operating margin is around 0.03, and net profit margin is approximately 0.006 as of the latest reports.

In what way does HAO's earnings per share (EPS) trend reflect its financial momentum?

Haoxi Health Technology Limited (HAO) EPS is -2.85 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Haoxi Health Technology Limited is -0.47, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Haoxi Health Technology Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Haoxi Health Technology Limited like P/E which is 331.27, P/B which is 5.25, and PEG which is -5.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Haoxi Health Technology Limited

HAO•NASDAQ

Communication Services

Advertising Agencies

$1.35

$-0.03(-2.18%)

Fundamental Analysis of Haoxi Health Technology Limited (HAO)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-2.85

P/E Ratio

-0.47

ROE

0.02%

Net Margin

0.006%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$26.19M

Shares OutstandingTotal number of shares issued

$19.40M

Book Value/ShareNet worth per share

$0.26

Revenue/ShareAnnual revenue per share

$0.68

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-2.85

Net MarginNet income as percentage of revenue

0.61%

Operating MarginOperating income as percentage of revenue

2.90%

ROEReturn on shareholders' equity

1.98%

ROAReturn on total assets

1.35%

ROCEReturn on capital employed

7.57%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.05

Cash/ShareCash and equivalents per share

$0.13

FCF YieldFree cash flow as percentage of market cap

-12.76%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for HAOFinancial Ratios Analysis details for HAO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for HAOSector Benchmarking details for HAO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Haoxi Health Technology Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Haoxi Health Technology Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Haoxi Health Technology Limited's unique business strengths and challenges.

Key Financial Metrics for Haoxi Health Technology Limited

For Haoxi Health Technology Limited, essential financial indicators include EPS -2.85, PE -0.47, and ROE 0.02. These key ratios reveal insights into Haoxi Health Technology Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Haoxi Health Technology Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Haoxi Health Technology Limited

Metrics like Net Margin 0.61% and ROA 1.35% shed light on how well Haoxi Health Technology Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Haoxi Health Technology Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Haoxi Health Technology Limited

Using ratios such as P/B Ratio 5.25 and PEG Ratio -5.00, investors can assess whether Haoxi Health Technology Limited is appropriately valued based on its financials and growth potential. These figures, combined with Haoxi Health Technology Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Haoxi Health Technology Limited

Financial health indicators, such as Debt/Equity Ratio 0.07 and Cash Flow $-0.05, provide a snapshot of Haoxi Health Technology Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Haoxi Health Technology Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Haoxi Health Technology Limited

Investing in Haoxi Health Technology Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Haoxi Health Technology Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;